Jan 5 () - Zenas BioPharma said on Monday its experimental drug cut the risk of disease flare-ups in a ​late-stage study of ...

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

With a goal of understanding and addressing immunotherapy's limitations, researchers at Washington University School of Medicine in St Louis have found that the immune system can be its own worst ...

Research reveals how a specific mutation in a protein called TRAF1 can shut down an overactive immune response, dramatically reducing inflammation in mice. This discovery could pave the way for a new ...

This is read by an automated voice. Please report any issues or inconsistencies here. There are more than 100 autoimmune diseases, affecting tens of millions as cases continue to rise, and 4 in 5 ...

Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection ...

What Is Opzelura, and Why Does It Matter? Opzelura (ruxolitinib) is a prescription cream that helps reduce skin inflammation. It works by blocking certain proteins in the body called Janus kinases ...

PHOENIX — Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth ...

The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...